Cargando…
Administration of pentoxifylline to improve anemia of hemodialysis patients
Introduction: One of the most important causes of erythropoietin-resistant anemia in end-stage renal disease (ESRD) patients is increased levels of inflammatory cytokines. Objectives: In this study pentoxifylline, an anti-inflammatory and anti-cytokine drug, with no significant side effects was used...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nickan Research Institute
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414521/ https://www.ncbi.nlm.nih.gov/pubmed/28487874 http://dx.doi.org/10.15171/jrip.2017.11 |